Antidotes or Ambiguity? Understanding the use of uridine triacetate and glucarpidase in chemotherapy toxicity.
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Antidotes or Ambiguity? Understanding the use of uridine triacetate and glucarpidase in chemotherapy toxicity.
-
Narrated by:
-
By:
About this listen
Brandy Hernandez, PharmD shares nuances on the use of uridine triacetate and glucarpidase in chemotherapy toxicity management
For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.
You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X @MayoMedE
No reviews yet